3 Results for "

NSD3-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NSD3-IN-3" in MCE Product Catalog:

Cat. No.: HY-142095
CAS No.: 445416-12-6
Purity:  ≥98.0%
Research Areas:  

Cancer

NSD3-IN-3 is a potent NSD3 inhibtor with an IC50 value of 1.86 μM. NSD3-IN-3 has anticancer activity and significantly inhibits the growth and proliferation of non-small cell lung cancer cell line H460 .
loading...
    loading...
Cat. No.: HY-162308
CAS No.: 744260-15-9
Research Areas:  

Cancer

NSD-IN-3 (compound 3) is a potent nuclear receptor binding SET domain (NSD) inhibitor. NSD-IN-3 inhibits NSD2-SET and NSD3-SET with IC50 values of 0.81 μM and 0.84 μM, respectively. NSD-IN-3 inhibits histone H3K36 dimethylation and decreases the expression of NSDs-targeted genes in non-small cell lung cancer cells. NSD-IN-3 induces s-phase cell cycle arrest and apoptosis .
loading...
    loading...
Cat. No.: HY-155816
CAS No.: 3033543-95-9
Purity:  99.40%
Target:  

PROTACs

Research Areas:  

Cancer

PROTAC NSD3 degrader-1 (compound 56) is a PROTAC targeting to Nuclear receptor binding SET domain protein NSD3. PROTAC NSD3 degrader-1 specifically induces NSD3 degradation with DC50 values of 1.43 and 0.94 μM in lung cancer cells NCI-H1703 and A549, respectively. PROTAC NSD3 degrader-1 suppresses the methylation of H3K36, induces apoptosis, and causes cell-cycle arrest. PROTAC NSD3 degrader-1 also downregulates the expression of NSD3-associated genes such as CDC25A, ALDH1A1, and IGFBP.
loading...
    loading...